Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Summary

This trial is studying the side effects and best dose of eribulin mesylate and cisplatin in treating patients with advanced solid tumors.Drugs used in chemotherapy, such as eribulin mesylate and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.

Timeline

Start

2006-12

Primary completion

2014-05

Completion

—

Drugs

Indications